HABP2 and neoplasm: We observed that HABP2 overexpression in SK-LU-1 human NSCLC cells increased cell motion, migration, transendothelial extravasation, tumor growth and metastasis, and activation of the extracellular serine protease, uPA, implicated in cancer progression.